ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy.
An enzyme-linked immunosorbent assay for urinary 6-beta-hydroxycortisol (6-beta-OHF) was developed. A highly specific antiserum against 6-beta-OHF-21-hemisuccinate bovine serum albumin (6-beta-OHF-21-HS-BSA) raised in rabbit was used. The enzyme-labelled hapten was prepared by the mixed anhydride method using horse radish peroxidase (HRP). The limit of detection is very low (10 pg), the intra-assay variation ranges from 5.2-6.6%, the inter-assay variation is 8.2-8.3%. Cross reactivities of various steroids are very low. The diurnal variations in urinary 6-beta-OHF and it's ratio to 17-hydroxycorticosteroids (17-OHCS) were studied in six healthy volunteers. No significant difference was found within the 24 h for the ratio of 6-beta-OHF to 17-OHCS. A large increase of 8-12 h urinary 6-beta-OHF was observed in patients receiving chronic treatment with antiepileptics.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000328:Adult; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002940:Circadian Rhythm; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000276:immunology / Q000652:urine; D008297:Male; D008875:Middle Aged; D011817:Rabbits; D012016:Reference Values
D015065:17-Hydroxycorticosteroids; D000927:Anticonvulsants; C001380:6 beta-hydroxycortisol; D006854:Hydrocortisone